Seedlabs

MAP Band: Age-Adjusted Blood Pressure Target Assistant for Septic Shock

A bedside tool that tells ICU nurses the target blood pressure for sepsis patients based on their age.

A bedside ICU decision-support module that sets each septic shock patient's mean arterial pressure target band from the 2026 guidelines — 65 mm Hg (within about 5 mm Hg) generally, but 60-65 mm Hg for patients 65 and older — and guides vasopressor titration to hold the band.

MedicineSepsis Diagnosis and Treatment
Metabolism and Genetic DisordersHospital critical care — ICU hemodynamic management and clinical decision support

Concept

MAP Band is a bedside critical-care decision-support module that computes each septic-shock patient's mean arterial pressure (MAP) target band automatically from the 2026 SSC guidelines and guides vasopressor titration to hold it. On septic-shock recognition, it sets the target: 65 mm Hg with the guideline's new remark that a range within about 5 mm Hg is what is actually maintainable for most adults, but 60-65 mm Hg for patients 65 and older, where the guidelines now endorse permissive hypotension. The module displays the band on the monitor and EHR, accepts either noninvasive cuff or arterial-line pressures (both now endorsed), and prompts the escalation sequence — norepinephrine first, add vasopressin, then epinephrine — only when the band cannot be held. The single wedge: stop titrating every elderly patient's MAP above 65 with escalating vasopressors when the 2026 guidelines say 60-65 is probably better for them.

Why now

  • The 2026 SSC guidelines issue a strong recommendation (moderate certainty) for an initial MAP target of 65 mm Hg over higher targets, with a new remark that MAP cannot be maintained at exactly 65 and vasopressors should be titrated to a range, e.g., within 5 mm Hg — titration-band logic no current bedside tool encodes.
  • New statement 14 conditionally suggests an initial MAP range of 60-65 mm Hg for adults 65 and older, based on a guideline meta-analysis restricted to older patients in which a lower blood pressure target was associated with reduced mortality at longest follow-up.
  • The escalation logic also changed: norepinephrine-first over vasopressin or angiotensin II was downgraded to conditional (statement 55), and epinephrine is the suggested add-on when MAP remains inadequate despite norepinephrine plus vasopressin (statement 57) — a nuanced sequence that is error-prone to recall at the bedside but trivial for a rules engine.
  • Statement 42 now endorses either invasive or noninvasive blood pressure monitoring, citing the EVERDAC RCT (1,010 patients; 28-day mortality 34.3% noninvasive vs 36.9% invasive, noninferior), settling a design constraint the module must meet.

Written by GLM · 10 Oct 2026

AI assessment

Backed by 1 paper92

A highly focused, evidence-backed clinical decision support tool that translates new 2026 guidelines into a concrete bedside titration logic to reduce over-treatment in elderly septic patients.

Evidence strength
5/5
The idea is directly mapped to specific, numbered statements from the 2026 SSC guidelines, including the new age-adjusted MAP targets and the EVERDAC RCT results.
Market pull
4/5
ICUs have high urgency to adhere to SSC guidelines to reduce mortality and avoid the complications of excessive vasopressor use, though integration into EHRs can be a procurement hurdle.
Novelty & moat
4/5
While other catalog ideas are CDS tools, this is the first to target the specific hemodynamic titration window for sepsis, filling a gap in active bedside management.
Feasibility
5/5
The logic is a simple rules engine (if age > 65, target = 60-65) that can be prototyped as a lightweight software module or EHR plugin.
Wedge clarity
5/5
The wedge is exceptionally sharp: stop the habit of titrating elderly patients above 65 mmHg when the new guidelines suggest a lower target is safer.
Simplicity / focus
5/5
The product is a single-purpose decision-support module with a clear input (age/BP) and a clear output (target band/drug sequence).

Scored by Gemma 4 · 10 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • Cleveland Clinicorganization

    A large ICU enterprise treating many elderly septic-shock patients; age-banded MAP targets standardize titration across intensivists and reduce excess vasopressor exposure in patients 65 and older.

  • Kaiser Permanenteorganization

    Its integrated ICUs serve an older population; embedding the 60-65 mm Hg band for patients 65 and older turns a nuanced new recommendation into consistent practice across many hospitals.

  • Edwards Lifesciencescompany

    Its hemodynamic monitoring platforms could embed the age-banded MAP target and titration display, giving ICUs guideline-aligned decision support on monitoring hardware they already own.

  • Baxter Internationalcompany

    Its smart infusion pumps deliver vasopressors; a target-band advisory encoding the 2026 escalation sequence (norepinephrine, then vasopressin, then epinephrine) aligns pump workflows with the new guidance.

Research it builds on

  1. Executive Summary: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
    Hallie C. Prescott, Massimo M. Antonelli, Waleed Alhazzani et al. · 2026 · 138 citations
    All ideas from this paper →
Leave feedback
feasibility